GlassScriptPhysician profile
Joanne E Bastille
NPI 1093368656
$718.45
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.68 · 2022: $101 · 2023: $392 · 2024: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $236.97 | 2022-2024 | |
| Novo Nordisk INC | $175.80 | 2021-2024 | Wegovy |
| Dexcom, INC. | $81.38 | 2023 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $75.07 | 2023-2024 | Rexulti |
| Glaxosmithkline, LLC. | $36.93 | 2022-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $32.51 | 2022-2023 | Farxiga |
| Alk-Abello, INC | $29.23 | 2023 | Odactra, Ragwitek, Grastek |
| Neurocrine Biosciences, INC. | $18.58 | 2024 | Ingrezza |
| Exact Sciences Corporation | $16.37 | 2023 | Cologuard Collection Kit |
| Lundbeck LLC | $15.61 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Bastille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.